Temasek, a Singapore-headquartered global investment company, will continue to hold a majority stake in Manipal
Mubadala Investment Company has announced that it is investing in Manipal Health Enterprises (Manipal).
Temasek, a Singapore-headquartered global investment company, will continue to hold a majority stake in Manipal.
Camilla Macapili Languille, Head of Life Sciences, Mubadala said, “Manipal is one of India’s leading healthcare networks, distinguishing itself through its commitment to clinical excellence, its strong patient-centric approach, and its impeccable standards of corporate governance. Given the ever-increasing demand for high-quality hospital care across India, we look forward to supporting Manipal’s growth journey in the years ahead.”